期刊文献+

糖化血红蛋白测定在糖尿病诊断中的临床意义 被引量:52

糖化血红蛋白测定在糖尿病诊断中的临床意义
下载PDF
导出
摘要 目的探讨糖化血红蛋白测定在糖尿病诊断中的临床意义。方法选择359例糖尿病患者为DM组,正常体检人员92例为对照组,研究两组空腹血糖与糖化血红蛋白的差异,及DM组中空腹血糖与糖化血红蛋白相关性,并以糖化血红蛋白大于8%为试验组,小于8%为对照组,研究两组别并发症及合并症的发生率。结果 DM组与对照组空腹血糖与糖化血红蛋白相比较差异有统计学意义;DM组中空腹血糖与糖化血红蛋白呈正相关,(r=0.634,P<0.01);糖化血红蛋白大于8%的试验组周围神经病变、脂肪肝、高血压、脑血管事件均高于糖化血红蛋白小于8%的组别。结论糖化血红蛋白的测定有助于糖尿病的诊断,对于糖尿病并发症及合并症的监控有重要临床意义。 Objective To investigate the determination of glycated hemoglobin in the diagnosis of diabetes clinical significance. Methods 359 patients with diabetes for the DM group, 92 cases of normal medical personnel for the control group to study the two groups of fasting plasma glucose and glycated hemoglobin differ- ences, and the DM group, fasting plasma glucose and glycosylated hemoglobin in the correlation, and glycated hemoglobin greater than 8% for the test group, less than 8% for the control group, two groups of complications and the incidence of complications. Results DM group and control group results of fasting plasma glucose and glycated hemoglobin compared to a statistically significant difference. DM group, fasting plasma glucose and gly- cared hemoglobin was positively correlated, ( r = 0. 634, P 〈 0.01 ) ; glycated hemoglobin greater than 8% of the test group peripheral neuropathy, fatty liver, hypertension, cerebrovascular events were higher than glycated hemoglobin less than 8% of the group. Conclusion Determination of glycated hemoglobin helps the diagnosis of diabetes, diabetic complications and complications for monitoring have important clinical significance.
作者 徐建国
出处 《中国实用医药》 2011年第30期28-29,共2页 China Practical Medicine
关键词 糖化血红蛋白 空腹血糖 糖尿病 Glycated hemoglobin Fasting glucose Diabetes
  • 引文网络
  • 相关文献

参考文献5

二级参考文献74

  • 1宋伟伟.GHb,SOD和LPO在NIDDM及其并发症中变化的临床意义[J].中华内分泌代谢杂志,1995,11(4):245-245. 被引量:9
  • 2钱荣立.蛋白非酶糖化与糖尿病慢性血管合并症[J].中华内分泌代谢杂志,1993,9(2):109-109.
  • 3Vlassara H.Advanced glycation in health and disease:Role of the modern environment.Ann.N.Y.Acad.Sci,2005,1043:452-460.
  • 4Rahbar S.The discovery of glycated hemoglobin:A major event in the study of nonenzymatic chemistry in biological systems.Ann N Y Acad Sci,2005,1043:9-19.
  • 5Jeffcoate SL.Diabetes control and complications:The role of glycated haemoglobin,25 years on.Diabet Med,2004,21:657-665.
  • 6Monnier VM,Sell DR,and Genuth S.Glycation products as markers and predictors of the progression of diabetic complications.Ann.N.Y.Acad.Sci,2005,1043:567-581.
  • 7Consensus Committee.Consensus statement on the worldwide standardization of the hemoglobin A1C measurement:The American Diabetes Association,European Association for the Study of Diabetes,International Federation of Clinical Chemistry and Laboratory Medicine,and the International Diabetes Federation.Diabetes Care,2007,30:2399-2400.
  • 8Geistanger A,Arends S,Berding C,et al.Statistical methods for monitoring the relationship between the IFCC reference measurement procedure for hemoglobin A1c and the designated comparison methods in the United States,Japan,and Sweden.Clinical Chemistry,2008,54:1379-1385.
  • 9Jeppsson1 JO,Kobold U,Barr J,et al.Approved IFCC reference method for the measurement of HbA1c in human blood.Clin Chem Lab Med,2002,40(1):78-89.
  • 10Hoelzel W,Weykamp C,Jeppsson JO,et al.IFCC reference system for measurement of hemoglobin A1c in human blood and the national standardization schemes in the United States,Japan,and Sweden:A method-comparison study.Clinical Chemistry,2004,50:166-174.

共引文献380

同被引文献409

引证文献52

二级引证文献217

;
使用帮助 返回顶部